Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool [version 2; peer review: 2 approved, 1 approved with reservations]
Background: The Portfolio-To-Impact (P2I) P2I model is a recently developed product portfolio tool that enables users to estimate the funding needs to move a portfolio of candidate health products, such as vaccines and drugs, along the product development path from late stage preclinical to phase II...
Main Authors: | Alexander Gunn, Shashika Bandara, Gavin Yamey, Flavia D´Alessio, Hilde Depraetere, Sophie Houard, Nicola K Viebig, Stefan Jungbluth |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-02-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1066/v2 |
Similar Items
-
Analysis of the health product pipeline for poverty-related and neglected diseases using the Portfolio-to-Impact (P2I) modeling tool [version 1; peer review: 2 approved]
by: Alexander Gunn, et al.
Published: (2020-05-01) -
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 1; referees: 1 approved, 2 approved with reservations]
by: Ruth Young, et al.
Published: (2018-04-01) -
Funding global health product R&D: the Portfolio-To-Impact Model (P2I), a new tool for modelling the impact of different research portfolios [version 2; referees: 2 approved]
by: Robert F Terry, et al.
Published: (2018-07-01) -
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 2; referees: 3 approved]
by: Ruth Young, et al.
Published: (2018-08-01) -
A quantitative analysis of sources of changes in government expenditures on health, 2000 to 2015: what can we learn from experience to date? [version 2; peer review: 1 approved, 2 approved with reservations]
by: Helen Saxenian, et al.
Published: (2021-08-01)